What is Retina Associates?
Established in 1991, Retina Associates is dedicated to providing state-of-the-art, compassionate care for a wide spectrum of retinal and vitreous disorders. The company's expertise spans the diagnosis and medical-surgical treatment of conditions such as macular degeneration, diabetic retinopathy, retinal detachment, and ocular trauma. With a strong emphasis on physician education and scientific investigation, Retina Associates actively participates in clinical trials to explore novel therapeutic approaches. The practice operates multiple offices across the Chicago metropolitan area, each equipped with advanced diagnostic and therapeutic instrumentation, reflecting its commitment to cutting-edge patient care and research.
How much funding has Retina Associates raised?
Retina Associates has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Retina Associates?
The substantial large-scale, late-stage funding signifies Retina Associates' readiness for significant expansion and further innovation. This strategic capital infusion is poised to accelerate the company's research initiatives, potentially leading to breakthroughs in vitreo-retinal disorder treatment. Furthermore, the investment will likely support the enhancement of its diagnostic and therapeutic capabilities across its network of offices, solidifying its position as a leader in specialized eye care and reinforcing its dedication to advancing ophthalmological science.
See full Retina Associates company page
